DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Lamond NW, Skedgel C, Younis T.
Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?.
Expert review of pharmacoeconomics & outcomes research 2013;
13: 243-250
We do not assume any responsibility for the contents of the web pages of other providers.